Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Auteurs : Azim HA, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart-Gebhart M, Peccatori FA
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(1)
Pagina's : 73-9

Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP).

Auteurs : Ades F, de Azambuja E, Daugaard G, Ameye L, Moulin C, Paesmans M, De Jong D, Decoster L, De Greve J, Ismael G, Møller AK, Piccart-Gebhart M, Awada A
Jaar : 2013
Journal : J Chemother
Volume : 25(4)
Pagina's : 239-46

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Auteurs : Berghmans T, Lafitte JJ, Scherpereel A, Paesmans M, Lecomte J, Marco VG, Meert AP, Leclercq N, Sculier JP
Jaar : 2013
Journal : Anticancer Res
Volume : 33(12)
Pagina's : 5477-82

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Auteurs : Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, CsToth I, Dernies T, Toussaint L, Leclercq N, Sculier JP
Jaar : 2013
Journal : Lung Cancer
Volume : 82(2)
Pagina's : 340-5

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.

Auteurs : de Azambuja E, Zardavas D, Lemort M, Rossari J, Moulin C, Buttice A, Dhondt V, Lebrun F, Lalami Y, Cardoso F, Sotiriou C, Gil T, Devriendt D, Paesmans M, Piccart-Gebhart M, Awada A
Jaar : 2013
Journal : Ann Oncol
Volume : 24(12)
Pagina's : 2985-9

Safety and Efficacy of Radioimmunotherapy with 90Yttrium-rituximab in Patients with Relapsed CD20+ B cell Lymphoma: A Feasibility Study

Auteurs : Vaes M, Bron D, Vugts DJ, Paesmans M, Meuleman N, Ghanem G, Vanderlinden B, Thielemans K, van Dongen GA, Flamen P, Muylle K
Jaar : 2012
Journal : J Cancer Sci Ther
Volume : 4(12)
Pagina's : 394-400

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Auteurs : Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, DHaens G, Paesmans M, Peeters M, Efira A, Humblet Y
Jaar : 2012
Journal : Acta Gastroenterol Belg
Volume : 75(1)
Pagina's : 14-21

Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.

Auteurs : Antoine C, Ameye L, Paesmans M, Rozenberg S
Jaar : 2012
Journal : Maturitas
Volume : 72(4)
Pagina's : 317-23

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.

Auteurs : Rossari JR, Metzger-Filho O, Paesmans M, Saini KS, Gennari A, de Azambuja E, Piccart-Gebhart M
Jaar : 2012
Journal : J Oncol
Volume : 2012
Pagina's : 417673

Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Wo

Auteurs : Berghmans T, Lafitte JJ, Giner V, Berchier MC, Scherpereel A, Lewin D, Paesmans M, Meert AP, Bosschaerts T, Leclercq N, Sculier JP
Jaar : 2012
Journal : Lung Cancer
Volume : 77(3)
Pagina's : 605-610

M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy.

Auteurs : Ameye L, Paesmans M, Thiel S, Jensenius JC, Aoun M
Jaar : 2012
Journal : Clin. Exp. Immunol.
Volume : 167(2)
Pagina's : 303-8

Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplasic syndrome: a bicentric study.

Auteurs : Vaes M, Hites M, Cotton F, Bourguignon AM, Csergo M, Rasson C, Ameye L, Bron D, Jacobs F, Aoun M
Jaar : 2012
Journal : Antimicrob. Agents Chemother.
Volume : 56(12))
Pagina's : 6298-303

The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer.

Auteurs : Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A, Gidron Y
Jaar : 2012
Journal : Auton Neurosci
Volume : 166(1-2)
Pagina's : 96-9

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Auteurs : Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, de Azambuja E, Piccart-Gebhart M
Jaar : 2012
Journal : Ann Oncol
Volume : 23(4)
Pagina's : 853-859

Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations.

Auteurs : Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, CsToth I, Garcia C, Giner V, Holbrechts S, Lafitte JJ, Lecomte J, Louviaux I, Markiewicz E, Meert AP, Richez M, Roelandts M, Scherpereel A, Tulippe Ch, Van Houtte P, van Schil P, Wachters C, Westeel V, Sculier JP
Jaar : 2012
Journal : Eur. Respir. J.
Volume : 39(1)
Pagina's : 9-28

Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

Auteurs : Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart-Gebhart M, Flamen P
Jaar : 2012
Journal : Ann Oncol
Volume : 23(7)
Pagina's : 1687-93

Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

Auteurs : Paesmans M, Klastersky J, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Ameye L
Jaar : 2011
Journal : Support Care Cancer
Volume : 19(7)
Pagina's : 1001-8

Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study.

Auteurs : Scherpereel A, Berghmans T, Lafitte JJ, Colinet B, Richez M, Bonduelle Y, Meert AP, Dhalluin X, Leclercq N, Paesmans M, Willems L, Sculier JP
Jaar : 2011
Journal : Eur. Respir. J.
Volume : 37(1)
Pagina's : 129-136

Surgical management of toxic multinodular goiter.

Auteurs : Digonnet A, Willemse E, Dekeyser C, de Saint-Aubain de Somerhausen N, Moreau M, Andry G
Jaar : 2011
Journal : World Journal of Endocrine Surgery
Volume : 3(2)
Pagina's : 69-73

Tomographie par émission de positons au 18F-FDG et réponse anticancéreuse. Détermination de la réponse à la chimiothérapie de première ligne des cancers bronchiques non à petites cellules avancés : critères métaboliques ou morphologiques ?

Auteurs : van Ruychevelt V, Garcia C, Meert AP, Berghmans T, Paesmans M, Flamen P, Sculier JP
Jaar : 2011
Journal : Rev Mal Respir
Volume : 28(5)
Pagina's : 618-25